跳至主要内容
临床试验/NCT06504628
NCT06504628已完成不适用

CHUtes Chez Les Personnes Agées traitées Pour Cancer Dans Les HOpitaUx Normands : repérage et Prévention

University Hospital, Caen10 个研究点 分布在 1 个国家目标入组 328 人开始时间: 2024年9月16日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
328
试验地点
10
主要终点
prevalence of each of the three levels of fall-risk

研究概览

简要总结

The French Plan National AntiChute (published on February 21, 2022) and international recommendations on falls prevention (Age Ageing,September 2022) recommend identifying the risk of falling in people aged 65 and over, at least once a year during a follow-up consultation. The presence of chronic illness such as cancer increases the risk for falling. Recommendations suggest targeted preventive interventions according to the risk level, and early reassessment at 3 months in case of high risk.

This study consists of a cross-sectional survey conducted during a week dedicated to patient safety (September 16-20, 2024), to identify the prevalence of patients at high risk for falling, requiring enhanced care. The relation between high risk for falling and social and oncological characteristics will be studied. A 3-month telephone follow-up will identify any obstacles to implementing the recommendations in this high-risk group.

This multicenter cross-sectional prospective study is exploratory.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • aged 65 or over
  • undergoing treatment for cancer or hematological malignancy (oral or injectable systemic treatment, radiotherapy)
  • covered by health insurance
  • having read the information document and no objection
  • French-speaking
  • Autonomous ( with occasional assistance with instrumental daily activities),

排除标准

  • refusal to participate
  • unable to communicate
  • dependent (requiring geriatric care)

结局指标

主要结局

prevalence of each of the three levels of fall-risk

时间窗: Day 1

describe the distribution of patients in mild, intermediate and high risk for falling

次要结局

  • Describe the rate of high-risk patients who will have benefited from (full or partial) implementation of recommended interventions according to 3-month follow-up.(3 mnths)
  • describe the Average number of STOPPFALL medications per patient. Rate of patients with at least one oncologydrug listed as a fall risk (CIPN), in the 3 fall risk categories(Day 1)
  • look for association between high-risk categorization and rural place of residence, gender, age bracket (65-74 and 75 and over), investigating center, type of cancer (location).(Day 1)
  • among high-risk patients followed up at 3 months, look for an association between the absence ofimplementation of recommendations and social, medical characteristics and motive(3 mnths)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验